Johnson: Google’s Debug Project Plans to Release 64 Million Bacteria-Infected Mosquitoes

Google’s Debug project is moving forward with plans to release 64 million bacteria-infected mosquitoes (32 million total, 16 million per year) across California and Florida over the next two years. These male mosquitoes carry Wolbachia bacteria intended to mate with wild females and make their offspring non-viable, crashing local populations.

This is a reckless, large-scale open-air biological experiment conducted on the American public without meaningful consent. Local communities get no real vote. Once released, these engineered insects cannot be recalled if unintended consequences emerge, including ecological disruption, impacts on other species, or unknown effects on human health. Continue reading

10 Healing Plants Every American Pharmacy Sold Before 1910 — and the Report That Erased Them All

Before modern pharmaceuticals dominated medicine, American pharmacies across the country regularly sold powerful plant-based remedies trusted by doctors, pharmacists, and families alike. From roots used to calm pain and herbs prescribed for illness to natural extracts once considered essential medicine, these healing plants filled pharmacy shelves before 1910 – but according to historical rumors and controversial reports from the early 20th century, many of these remedies suddenly vanished from mainstream treatment almost overnight.

Continue reading

The One Vegetable Dietitians Recommend for Brain, Heart, and Gut Health

(Plus, a few honorable mentions.)

Vegetables are a cornerstone of a healthy diet, but with endless options at the market and seasons that never stop shifting, knowing which ones to always keep on hand isn’t always obvious. We asked two registered dietitians to name their standout pick (and share a few honorable mentions) to settle the debate once and for all. Spoiler: Eat your greens. Continue reading

Colorectal Cancer Screening Guidelines Include New Alternative to Colonoscopy

The American Cancer Society (ACS) has updated its guidelines for colorectal cancer screening to include new blood-based and at-home stool tests.

The new blood test screens for tumor DNA, while the at-home tests look for DNA, RNA, and blood markers in stool samples.

The updated guidelines still retain ACS recommendations for starting colorectal cancer screening at age 45 and having colonoscopies done every 10 years for people who are at average risk of colorectal cancer.

The organization published its new recommendations on May 27 in CA: A Cancer Journal for Clinicians.  Continue reading

The 6 Cancer-Fighting Foods a Top MD Swears by To Boost Immunity and Curb Inflammation

Dr. Joel Fuhrman shares his ‘G-BOMBS‘ – acronym for the superfoods that help block cancer cell growth

What if you could protect yourself from several different types of cancer with foods you already love? We often hear that food is medicine, but some superfoods are better than the rest at staving off serious illnesses such as cancer. So we turned to nutrition expert Joel Fuhrman, MD, author of countless best-selling health books including Super Immunity and Eat for Life, to find out his favorite cancer-fighting foods. Turns out he has an easy way to remember the top picks in his anticancer nutrition protocol. Read along to learn his simple acronym and discover exactly why these foods should be added to your plate. Continue reading

The Most Lethal Cancers Get Shortchanged by Federal Funding

Highest death risk for SCLC, pancreatic cancer, but not reflected in average funding per death

Highly lethal cancers received disproportionately less federal funding compared with other cancers that have better survival odds, according to a study by researchers at the National Cancer Institute.

An analysis of nine types of cancer showed that small-cell lung cancer (SCLC) and pancreatic cancer had the highest mortality-to-incidence ratios (MIRs) but received less funding per death during fiscal year 2025 than breast cancer and prostate cancer, which had the two lowest MIRs.

Funding per death averaged $2,818 for SCLC and $8,945 for pancreatic cancer as compared with $69,800 and $126,992 for breast and prostate cancer, respectively. Liver cancer and non-small cell lung cancer (NSCLC) had the third and fourth highest MIRs and received $10,447 and $1,754 per death, respectively. Continue reading

Recently Surfaced CIA Document Reveals Research Hinted at Potential Treatments for Cancer Years Ago

Growth: Cancer cells, the pictured are kidney cancer cells magnified 1,300 times, develop through a series of trial and error mutations and clump to form tumours, which may invade and destroy surrounding tissues

A recently surfaced CIA document proves the intelligence agency reviewed Cold War–era research that hinted at potential treatments for cancer 75 years ago — and kept the remarkable report classified for decades, according to a new report.

Now, the outraged public is speaking out and alleging a cruel government cover-up. Continue reading

Another Blood Pressure Medication Has Been Recalled Nationwide

It also treats heart conditions but is the latest in a string of drugs treating these conditions that’s being flagged for quality concerns.

In the past year, multiple hypertension medications have been recalled due to the suspected development of chemical compounds, called nitrosamines, that are linked with cancer. The compounds can occur inadvertently over time or due to environmental and other conditions.

In a Food and Drug Administration (FDA) report published last week comes the latest blood pressure medication recall. A May 5 FDA notice revealed that on April 23, Unique Pharmaceutical Laboratories (a division of JB Chemicals and Pharmaceuticals Ltd) in India recalled 675 bottles of Enalapril Maleate Tablets in 1,000-count bottles, containing 20-milligram dosages. The product was then distributed by New Jersey-based Rising Pharma Holdings, Inc. Continue reading

Colonoscopy: The Most Used Screening Test for Colon Cancer, Here Are the Benefits and Risks

There is ongoing debate about who should undergo a colonoscopy and when.

Colonoscopy is the most widely used screening test for colon cancer, which is the second leading cause of cancer-related death in the United States.

It is considered the gold standard and is more accurate than two other common screening methods—stool tests and sigmoidoscopy—because it allows doctors to see the entire colon and remove any potentially problematic polyps during the same procedure.

However, there is ongoing debate about who should undergo a colonoscopy and when. Not everyone will get colon cancer, and the procedure could lead to overdiagnosis as well as rare but serious side effects. Continue reading

The Loophole Drug Makers Use to Keep Prices High

How pharmaceutical companies use the patent system to delay generic drugs from coming to market.

Bob Parant left his home on Long Island for the first time when he enrolled in college. Always interested in sports, he decided to try out for the football team in his sophomore year.

One day, Parant got a message to report to the athletic office.

“The coach calls me in and says, ‘You’ve got diabetes mellitus,’” Parant said. “That was back in 1972, and that’s where it started.”

Parant, now 73, has been living with diabetes for over 50 years. Continue reading

In 1913 the Rockefellers Bought Every Herbal School in America — Then Closed Them All by 1925

This video explores the controversial claims, the transformation of medicine in the early 20th century, and the questions that still remain unanswered today. If you’re interested in hidden history, powerful families, and the turning points that shaped the modern world, this is a story you won’t want to miss.

.

In 1913, at the height of industrial expansion, the powerful Rockefeller family began making quiet but strategic moves across the United States – moves that would forever change the future of medicine. This is the story of how they allegedly acquired influence over herbal schools across the country… and why, by 1925, many of them had disappeared without explanation.

At a time when natural remedies, plant-based healing, and traditional medicine were still widely practiced, these schools represented a completely different approach to healthcare. Communities relied on them. Generations trusted them. But as modern pharmaceutical systems began to rise, a shift started to happen. Funding changed. Regulations tightened. And slowly, these institutions began to close their doors one by one.

What really happened behind the scenes? Was it simply progress and standardization of medical education, or something more deliberate? As the influence of major industrial families grew, so did the dominance of a new medical model – one rooted in laboratories, chemicals, and large-scale production. And with that shift, older methods seemed to vanish almost overnight.

His Wife’s Terminal Cancer Drug Was Quoted at $13,000 Monthly. Then He Found It For $40

When Debbie Rhodes (pictured with husband Randy) filled her prescription for imatinib for the first time, their local pharmacist in Leawood, Kansas, shared in their relief, noting that the drug’s out-of-pocket cost ranged from $13,000 to $15,000 per month. The medication worked wonders: After starting the treatment, Debbie’s blood work showed the drug was keeping her cancer from progressing (Debbie and Randy Rhodes)

When Debbie Rhodes was diagnosed nine years ago with a terminal blood and bone marrow cancer,an unlikely hero would ultimately come to the rescue: Shark Tank star and billionaire, Mark Cuban. Continue reading

A 43-Year Harvard Study of 130,000 People Found 2 to 3 Cups of Coffee a Day Cut Dementia Risk by 35%

For more than four decades, researchers at Harvard tracked the diets and health outcomes of over 130,000 nurses and health professionals across the United States. When the team, led by senior author Daniel Wang, finally analyzed the data on coffee and cognitive decline, one finding stood out: participants who drank two to three cups of coffee a day had a 35% lower risk of developing dementia compared with those who drank little or none. The results, published as a peer-reviewed study in JAMA Network Open, land at a moment when global dementia cases are projected to nearly triple by 2050, according to the World Health Organization. Continue reading